{"DataElement":{"publicId":"11105678","version":"1","preferredName":"Cytokine Release Syndrome Hypotension Attribution Type","preferredDefinition":"The Cytokine Release Syndrome (CRS) description for the participant's hypotension (not attributable to any other cause).","longName":"CRSHYPOT_RSORRES","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"11023407","version":"1","preferredName":"Cytokine Release Syndrome Hypotension Attribution","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening._Blood pressure that is abnormally low.:To assign to a cause or source.","longName":"11023406v1.00:2493589v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"11023406","version":"1","preferredName":"Cytokine Release Syndrome Hypotension","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening._Blood pressure that is abnormally low.","longName":"C78251:C3128","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Release Syndrome","conceptCode":"C78251","definition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypotension","conceptCode":"C3128","definition":"Blood pressure that is abnormally low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D50950-CA5E-17ED-E053-731AD00A5F74","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2493589","version":"1","preferredName":"Attribution","preferredDefinition":"assigning to a cause or source.","longName":"C25358","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Attribution","conceptCode":"C25358","definition":"To assign to a cause or source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17726EBC-10DE-2E0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"ONEDATA","dateModified":"2006-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D50950-CA5F-17ED-E053-731AD00A5F74","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"11020951","version":"1","preferredName":"CRS Description Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"11020951v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":null,"ValueMeaning":{"publicId":"3030997","version":"1","preferredName":"None","longName":"3030997","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82DD865C-2FEA-9DF4-E040-BB89AD434EAA","latestVersionIndicator":"Yes","beginDate":"2010-03-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5D4F0EF-C7AA-14F2-E053-731AD00A7711","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-09","deletedIndicator":"No"},{"value":"Not requiring vasopressors","valueDescription":null,"ValueMeaning":{"publicId":"11023402","version":"1","preferredName":"Vasopressor Requirement Negation","longName":"11023402v1.00","preferredDefinition":"Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure._Something that is a necessary condition; something that is obligatory._An operation in which a term denies or inverts the meaning of another term or construction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vasopressor","conceptCode":"C126567","definition":"Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D4F0EF-C7A7-14F2-E053-731AD00A7711","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5D4F0EF-C7AB-14F2-E053-731AD00A7711","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-09","deletedIndicator":"No"},{"value":"Requiring a vasopressor with or without vasopressin","valueDescription":null,"ValueMeaning":{"publicId":"11023403","version":"1","preferredName":"Vasopressor Requirement With Without Arginine-Vasopressin","longName":"11023403v1.00","preferredDefinition":"Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure._Something that is a necessary condition; something that is obligatory._Used to indicate the presence of something or someone._Used to indicate the absence or lack of something or someone._Arginine-vasopressin (9 aa, ~1 kDa) is encoded by the human AVP gene. This protein is involved in peripheral blood vessel vasoconstriction and antidiuretic action in the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vasopressor","conceptCode":"C126567","definition":"Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Arginine-Vasopressin","conceptCode":"C2285","definition":"Arginine-vasopressin (9 aa, ~1 kDa) is encoded by the human AVP gene. This protein is involved in peripheral blood vessel vasoconstriction and antidiuretic action in the kidney.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D4F0EF-C7A8-14F2-E053-731AD00A7711","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5D4F0EF-C7AC-14F2-E053-731AD00A7711","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-09","deletedIndicator":"No"},{"value":"Requiring multiple vasopressors (excluding vasopressin)","valueDescription":null,"ValueMeaning":{"publicId":"11023404","version":"1","preferredName":"Multiple Vasopressor Requirement","longName":"11023404v1.00","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure._Something that is a necessary condition; something that is obligatory.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Vasopressor","conceptCode":"C126567","definition":"Any substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D4F0EF-C7A9-14F2-E053-731AD00A7711","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5D4F0EF-C7AD-14F2-E053-731AD00A7711","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5D4DDA4-305C-12C4-E053-731AD00A3E15","latestVersionIndicator":"Yes","beginDate":"2022-08-09","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-09","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CYTOKN_ATTR_TYP","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Select the CRS description for the participant's hypotension (not attributable to any other cause)","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617B8C4-E21D-7064-E053-731AD00AABD2","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}